8BN Stock Overview
Engages in the research, cultivation, processing, extraction, and distribution of psilocybin, psilocin, other psychedelic substances, and functional mushrooms for health and wellness markets in Canada and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Optimi Health Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.29 |
| 52 Week High | CA$0.29 |
| 52 Week Low | CA$0.093 |
| Beta | 1.21 |
| 1 Month Change | 25.22% |
| 3 Month Change | 42.57% |
| 1 Year Change | 94.59% |
| 3 Year Change | -36.56% |
| 5 Year Change | n/a |
| Change since IPO | -39.80% |
Recent News & Updates
Recent updates
Shareholder Returns
| 8BN | DE Food | DE Market | |
|---|---|---|---|
| 7D | 20.0% | 1.1% | 0.1% |
| 1Y | 94.6% | -10.8% | 9.1% |
Return vs Industry: 8BN exceeded the German Food industry which returned -10.8% over the past year.
Return vs Market: 8BN exceeded the German Market which returned 9.1% over the past year.
Price Volatility
| 8BN volatility | |
|---|---|
| 8BN Average Weekly Movement | 14.7% |
| Food Industry Average Movement | 4.8% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.5% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 8BN's share price has been volatile over the past 3 months.
Volatility Over Time: 8BN's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2020 | n/a | Bill Ciprick | www.optimihealth.ca |
Optimi Health Corp. engages in the research, cultivation, processing, extraction, and distribution of psilocybin, psilocin, other psychedelic substances, and functional mushrooms for health and wellness markets in Canada and internationally. The company offers raw mushroom biomass, mushroom extracts, and mushroom supplements, as well as a range of fungi varieties, including Lion’s Mane, Chaga, Reishi, Turkey Tail, and Cordyceps. It sells its products through www.optimilife.com, an e-commerce website platform; and Amazon marketplace, and distributors/brokers.
Optimi Health Corp. Fundamentals Summary
| 8BN fundamental statistics | |
|---|---|
| Market cap | €26.26m |
| Earnings (TTM) | -€3.54m |
| Revenue (TTM) | €160.95k |
163.2x
P/S Ratio-7.4x
P/E RatioIs 8BN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 8BN income statement (TTM) | |
|---|---|
| Revenue | CA$238.62k |
| Cost of Revenue | CA$234.87k |
| Gross Profit | CA$3.74k |
| Other Expenses | CA$5.25m |
| Earnings | -CA$5.24m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.058 |
| Gross Margin | 1.57% |
| Net Profit Margin | -2,196.76% |
| Debt/Equity Ratio | 21.3% |
How did 8BN perform over the long term?
See historical performance and comparison